88kda tumorigenic growth factor and antagonists

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/18 (2006.01) A01N 43/04 (2006.01) A61K 31/70 (2006.01) A61K 31/7088 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C07K 14/475 (2006.01) C07K 16/22 (2006.01) C12N 15/63 (2006.01) C12Q 1/68 (2006.01) G01N 33/567 (2006.01) G01N 33/574 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2290602

This invention relates to products and methods for treating cancer and for diagnosing tumorigenicity and other diseases associated with alteration in GP88 expression or action. Antagonists to an 88KDa autocrine growth and tumorigenicity stimulator are provided which inhibit its expression or biological activity. The antagonists include antisense oligonucleotides and antibodies.

L'invention concerne des produits et des méthodes permettant de traiter le cancer et de diagnostiquer l'action tumorigène et d'autres maladies associées à une altération dans l'expression ou l'action de GP88. L'invention concerne également des antagonistes d'un activateur de la croissance autocrine et l'action tumérogène de 88 Kda, lesdits antagonistes inhibant son expression ou son activité biologique. Ces antagonistes comprennent notamment des oligonucléotides et des anticorps antisens.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

88kda tumorigenic growth factor and antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 88kda tumorigenic growth factor and antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 88kda tumorigenic growth factor and antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1487676

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.